259 related articles for article (PubMed ID: 35993245)
41. MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
Sahoo S; Meijles DN; Al Ghouleh I; Tandon M; Cifuentes-Pagano E; Sembrat J; Rojas M; Goncharova E; Pagano PJ
PLoS One; 2016; 11(5):e0153780. PubMed ID: 27144530
[TBL] [Abstract][Full Text] [Related]
42. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
43. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
Habbout K; Omura J; Awada C; Bourgeois A; Grobs Y; Krishna V; Breuils-Bonnet S; Tremblay E; Mkannez G; Martineau S; Nadeau V; Roux-Dalvai F; Orcholski M; Jeyaseelan J; Gutstein D; Potus F; Provencher S; Bonnet S; Paulin R; Boucherat O
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803922
[TBL] [Abstract][Full Text] [Related]
44. PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis.
He Z; Chang T; Chen Y; Wang H; Dai L; Zeng H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047359
[TBL] [Abstract][Full Text] [Related]
45. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
[No Abstract] [Full Text] [Related]
46. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
[No Abstract] [Full Text] [Related]
47. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.
Archer SL; Marsboom G; Kim GH; Zhang HJ; Toth PT; Svensson EC; Dyck JR; Gomberg-Maitland M; Thébaud B; Husain AN; Cipriani N; Rehman J
Circulation; 2010 Jun; 121(24):2661-71. PubMed ID: 20529999
[TBL] [Abstract][Full Text] [Related]
49. DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects.
Yu J; Wilson J; Taylor L; Polgar P
J Cell Biochem; 2015 Mar; 116(3):386-97. PubMed ID: 25290246
[TBL] [Abstract][Full Text] [Related]
50. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
51. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
52. The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension.
Yamaguchi Y; Hosokawa S; Haraguchi G; Kajikawa Y; Sakurai M; Ishii T; Ando N; Morio T; Doi S; Furukawa T
J Pharmacol Exp Ther; 2023 May; 385(2):88-94. PubMed ID: 36849413
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
54. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
Courboulin A; Barrier M; Perreault T; Bonnet P; Tremblay VL; Paulin R; Tremblay E; Lambert C; Jacob MH; Bonnet SN; Provencher S; Bonnet S
Eur Respir J; 2012 Sep; 40(3):618-29. PubMed ID: 22496325
[TBL] [Abstract][Full Text] [Related]
55. Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.
Sutendra G; Dromparis P; Bonnet S; Haromy A; McMurtry MS; Bleackley RC; Michelakis ED
J Mol Med (Berl); 2011 Aug; 89(8):771-83. PubMed ID: 21809123
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
Liu C; Wan N; Wei L; Rong W; Zhu W; Xie M; Zhang Y; Liu Z; Jing Q; Lyu A
Vascul Pharmacol; 2023 Dec; 153():107233. PubMed ID: 37742818
[TBL] [Abstract][Full Text] [Related]
57. LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Zucker MM; Wujak L; Gungl A; Didiasova M; Kosanovic D; Petrovic A; Klepetko W; Schermuly RT; Kwapiszewska G; Schaefer L; Wygrecka M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1604-1616. PubMed ID: 30910704
[TBL] [Abstract][Full Text] [Related]
58. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
59. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
60. Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension.
Ye B; Peng X; Su D; Liu D; Huang Y; Huang Y; Pang Y
Clin Exp Hypertens; 2022 Jul; 44(5):470-479. PubMed ID: 35507763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
